Pages that link to "Q73295495"
Jump to navigation
Jump to search
The following pages link to Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia (Q73295495):
Displaying 50 items.
- In vivo maturation of human frataxin (Q24304209) (← links)
- Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism (Q24305348) (← links)
- Friedreich's Ataxia: A Neuronal Point of View on the Oxidative Stress Hypothesis (Q26830073) (← links)
- Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster delivery (Q26850111) (← links)
- Therapeutic developments in Friedreich ataxia (Q26861733) (← links)
- Oxidative stress and pulmonary fibrosis (Q27024861) (← links)
- Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia (Q27934042) (← links)
- Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency (Q28200651) (← links)
- The Friedreich's ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals (Q28292543) (← links)
- Sensitivity of respiratory chain activities to lipid peroxidation: effect of vitamin E deficiency (Q28344463) (← links)
- The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia (Q28475804) (← links)
- Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia (Q28488251) (← links)
- Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models (Q28540063) (← links)
- Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia (Q28551371) (← links)
- Mitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson's disease (Q28592188) (← links)
- Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia (Q28593887) (← links)
- Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model (Q28743986) (← links)
- Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome (Q30469947) (← links)
- Autosomal recessive cerebellar ataxias (Q31078351) (← links)
- Mitochondrial dysfunction induced by frataxin deficiency is associated with cellular senescence and abnormal calcium metabolism (Q33634010) (← links)
- GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology (Q33743762) (← links)
- MutLα heterodimers modify the molecular phenotype of Friedreich ataxia (Q33817381) (← links)
- Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects (Q33832717) (← links)
- Functional characterization of Friedreich ataxia iPS-derived neuronal progenitors and their integration in the adult brain (Q33856264) (← links)
- Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts (Q33936940) (← links)
- Hepatic mitochondrial dysfunction in Friedreich ataxia (Q34075023) (← links)
- Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities (Q34076650) (← links)
- Intracellular iron transport and storage: from molecular mechanisms to health implications (Q34100135) (← links)
- Friedreich's ataxia and iron metabolism (Q34101152) (← links)
- Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. (Q34135061) (← links)
- Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia (Q34143936) (← links)
- Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia (Q34150158) (← links)
- (1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. (Q34172946) (← links)
- Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts (Q34235344) (← links)
- Histopathology and molecular genetics of hearing loss in the human (Q34384188) (← links)
- Novel frataxin isoforms may contribute to the pathological mechanism of Friedreich ataxia (Q34452330) (← links)
- Friedreich ataxia: a paradigm for mitochondrial diseases (Q34524337) (← links)
- Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals (Q34546241) (← links)
- Molecular insights into Friedreich's ataxia and antioxidant-based therapies (Q34688287) (← links)
- Primary and secondary defects of the mitochondrial respiratory chain (Q34757220) (← links)
- Cytopathies involving mitochondrial complex II. (Q34856408) (← links)
- Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus (Q34984786) (← links)
- Genetic ataxia (Q34997868) (← links)
- Estrogen protection in Friedreich's ataxia skin fibroblasts (Q35046921) (← links)
- Frataxin and frataxin deficiency in Friedreich's ataxia (Q35076898) (← links)
- Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome (Q35090105) (← links)
- Iron in neurodegenerative disorders (Q35112542) (← links)
- Base excision repair of chemotherapeutically-induced alkylated DNA damage predominantly causes contractions of expanded GAA repeats associated with Friedreich's ataxia. (Q35137677) (← links)
- Gene expression profiling of mitochondrial oxidative phosphorylation (OXPHOS) complex I in Friedreich ataxia (FRDA) patients. (Q35140340) (← links)
- Friedreich's ataxia: treatment within reach (Q35172410) (← links)